Company Profile

Valitor Inc
Profile last edited on: 4/28/22      CAGE: 66NM0      UEI: MAUBKJ5FZ2K5

Business Identifier: Modifying therapeutic proteins to achieve substantial control over their pharmacokinetics
Year Founded
2010
First Award
2012
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

820 Heinz Avenue
Berkeley, CA 94710
   (510) 969-9246
   info@valitorbio.com
   www.valitorbio.com
Location: Single
Congr. District: 13
County: Alameda

Public Profile

Organized around development of advanced, protein-based drugs, Valitor, Inc. is a biotechnology company having worked on a method of modifying existing drugs to control their biological activity and stabilize their structure in the body. Using that core technology, Valitor is able to modify existing biological therapies to achieve substantial control over their pharmacological properties. The mission is to develop a new generation of biologic therapies having the impact of reducing the costs associated with effective treatment of these diseases. With a pipeline of drug products used to treat a variety of diseases, the objective is also to improve the patients’ quality of life by reducing the required frequency of therapeutic administration

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Wesley M Jackson -- CEO

  Kevin Healy -- Co-Founder

  Jesse McFarland -- Former Director of Process Development

  David Schaffer -- Co-Founder

  Amy Twite -- Director of Chemistry

Company News

There are no news available.